Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(137)
•••
MoneyMouth
X
View Profile
View Bullboard History
Comment by
MoneyMouth
on May 18, 2022 12:20pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LifeSci Communications
They're gonna be even happier when they are forced to purchase shares at $2.50 at the end of August. I feel like this point is being glossed over. That's a 63% premium to what they bought at
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 18, 2022 11:13am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LifeSci Communications
Bids at 1.43 and droppping! Now that the deal is done, it doesn't need to be range bound anymore. Maybe 1.20 is next logical stop? Great way to start a relationship, pump the price by leaking news
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on May 18, 2022 10:56am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LifeSci Communications
Oh Myrtles...put down your hand and go back to your seat in the corner. Bio likes you...he really, really likes you.
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on May 18, 2022 10:28am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LifeSci Communications
Biotek. You are most certainly right about stocky. I think he probably enjoyed watching.
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on May 18, 2022 10:13am
RE:Shorts
Sorry Charley, but it won’t work that way (IMO), at least not for a while yet.. Strategic partnerships are nothing new for Evotec and 20 million euros is chump change to them…lots of upside if things
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 18, 2022 9:49am
RE:RE:RE:RE:RE:RE:RE:RE:RE:LifeSci Communications
SVA shareholders should be warned from the disgusting pumping done by the few here who know the least about the stock. Red is the only pumpster with knowledge of the stock. Trickling back to the 1.40s
...more
(239)
•••
Charly50
X
View Profile
View Bullboard History
Post by
Charly50
on May 18, 2022 8:48am
Shorts
....man could also say the price gap is closed and the shorties have to stock up.
(239)
•••
Charly50
X
View Profile
View Bullboard History
Comment by
Charly50
on May 18, 2022 8:16am
RE:SVA needs to list on the TSX!
Hello Rix, nice to read from you again. I hope you survived the move well and feel comfortable in your new home. a warm welcome back.
(2)
•••
Treesh
X
View Profile
View Bullboard History
Comment by
Treesh
on May 18, 2022 8:16am
RE:SVA needs to list on the TSX!
Agreed. Why they would participate in investor conferences while still trading on the vulture exchange is beyond me. Embarrassing.
(239)
•••
Charly50
X
View Profile
View Bullboard History
Comment by
Charly50
on May 18, 2022 8:12am
RE:Echelon Raising SVA Price Target to $3.75 (from $3.25)
That s we need...
(134)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on May 18, 2022 6:52am
SVA needs to list on the TSX!
Seems like no matter what SVA announces the shares don't react positively, so short of being sold, SVA shares will continue to be react the same way. Many institutional investors only invest in
...more
(14)
•••
lupusalpha
X
View Profile
View Bullboard History
Post by
lupusalpha
on May 18, 2022 5:55am
Echelon Raising SVA Price Target to $3.75 (from $3.25)
Stem Cell Supply Deal “In the Bag” as Strategic Investment Further De-Risks Cell Pouch Technology; Raising PT to $3.75 (from $3.25)
(239)
•••
Charly50
X
View Profile
View Bullboard History
Comment by
Charly50
on May 18, 2022 5:07am
RE:RE:RE:RE:RE:RE:RE:RE:RE:LifeSci Communications
Indeed... They are two little ones who believe that if they join together.., they'll make something big. Whenever the matter is not going on, they resort to this means: insult. They hide
...more
(239)
•••
Charly50
X
View Profile
View Bullboard History
Comment by
Charly50
on May 18, 2022 4:41am
RE:RE:RE:RE:Sad day
Exactly ! The collaboration with Evotec, making Sernova risk-free, will attract institutional investors attract institutional investors. In contrast to private investors, they do not act
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >